PHVS - CIK 0001830487
Pharvaris N.V. trades as PHVS and has a market capitalization of $2.05 B, making it the #2084 largest US-listed company by market value. This page tracks Pharvaris N.V. through 254 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade (amended) | 4/A | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-21 |
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update - Pharvaris N.V.
Pharvaris Announces Positive Topline Data from RAPIDe-3 Pivotal Study Confirming Potential of Deucrictibant for On-Demand Treatment of HAE Attacks - Pharvaris N.V.
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update - Pharvaris N.V.
The largest companies sharing Pharvaris N.V.'s SEC industry classification (pharmaceutical preparations).
Pharvaris N.V. (PHVS) has a market capitalization of $2.05 B as of 2026-06-11, ranking #2084 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.